Tender detail

Purchase of anti-constipation medicines (A06)

Summary

The tender concerns the purchase of anti-constipation medicines (A06) for a 24-month period. The procurement is divided into 3 lots, and each lot is evaluated separately. A bidder may submit offers for up to 3 lots and may be awarded up to 3 lots. The notice includes exclusion grounds and qualification requirements, including proof of prior sales contracts for the relevant product group in the last 36 months.

Reference number
311911-0000
Buyer
Sihtasutus NARVA HAIGLA
Country
Estonia (EST)
Procedure
Simplified procurement
CPV
33613000 Laxatives
Deadline
2026-06-29
Status
Open
Contract subject
Supplies
Estimated value
Not published
Source
RHR

Participation requirements

Tender requirements are available in the official tender documents.

Compliance requirements

The bidder must confirm the standard exclusion grounds, including that neither the bidder nor members of its management bodies have been finally convicted within the last 5 years for participation in a criminal organisation, corruption, fraud, or offences related to a terrorist act or terrorist activity. The machine-readable notice listed these grounds, but all details and any additional conditions must be checked in the tender documents. If an exclusion ground applies, the bidder may submit evidence of self-cleaning measures to restore reliability, where permitted.

Qualification criteria and exclusion grounds

The bidder must demonstrate technical and professional capacity through previous sales contracts. For each lot, the bidder must show that it has performed at least 3 sales contracts for the relevant product within the previous 36 months and provide the value, dates and other contracting parties for those contracts. The requirements apply separately to the lots: 1) A06AD11 Lactulosum, oral solution, 650–670 mg/ml 100 ml; 2) A06AD81 Natrii sulfas anhydricus + Kalii chloridum + Natrii chloridum + Macrogolum + Natrii hydrogencarbonas, powder; 3) A06AG11 Laurilsulfas + Sorbitolum + Natrii citras, rectal solution, 9 mg + 625 mg + 90 mg 5 ml. Under the compliance requirements, the bidder must confirm that the bid complies with the tender documents, submit a joint-bid power of attorney if bidding jointly, justify any trade secrets, and complete and submit Annex 2, the price quotation form. The machine-readable notice did not include any other precise qualification or compliance requirements; these must be checked in the tender documents.